Loading tape…Loading tape…
WST
WST
WST
A Zacks report titled 'Reasons to Add West Pharmaceutical Stock to Your Portfolio Now' highlights West Pharmaceutical Services Inc as it shows full-year revenue of approximately $3.07 billion. The company currently holds a market capitalization of $23.93 billion and trades at a PE ratio of 43.20. Alongside these valuation levels, its TTM EPS stands at 7.98 with a free cash flow yield of 1.83%.
Based on zacks.comWest Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?
West Pharmaceutical Services (NYSE:WST) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell?
Meta, JPMorgan, West Pharmaceutical And More: CNBC's ‘Final Trades'
Top 50 High-Quality Dividend Growth Stocks For October 2026
West to Host Third-Quarter 2026 Conference Call
West Pharma: Still A Buy, But Expectations Are Rising
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.